Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research

ECN’s San Antonio site reaches 100% enrollment target six weeks ahead of schedule on Phase 3 SGLT2 inhibitor study.

ECN’s San Antonio site reaches 100% enrollment target six weeks ahead of schedule on Phase 3 SGLT2 inhibitor study.